Elon Musk’s brain-chip startup, Neuralink, has received the US Food and Drug Administration’s “breakthrough device” designation for the company’s experimental implant, Blindsight.
Neuralink’s technology includes a brain implant that reads neural signals and wirelessly transmits them to external devices, including computers and mobile devices.
